Return to Publications
September 2017
The latest news on research, treatment, prevention and education from the state's only National Cancer Institute-designated Comprehensive Cancer Center
DNA

$4M Aids Collaborative Research on DNA by Rutgers Cancer Institute and National Cancer Institute

Rutgers Cancer Institute of New Jersey and the National Cancer Institute's Center for Cancer Research are collaborating on work examining DNA repair in cancer thanks to $4 million in support including $2 million from the Robert Wood Johnson Foundation. The two-year project will explore new drug development along with how to optimize existing drugs for the treatment of cancers that arise due to mistakes made in the repair of DNA.

H. Richard Alexander, MD, FACS

Internationally Known Surgeon Named Chief Surgical Officer at Rutgers Cancer Institute

Expanding its surgical and research focus on cancers of the abdominal area and rare conditions including endocrine and mesothelioma malignancies, Rutgers Cancer Institute of New Jersey has named H. Richard Alexander, MD, FACS, as its new chief surgical officer. He also has an appointment as a professor of surgery in the Division of Surgical Oncology at Rutgers Robert Wood Johnson Medical School and will be part of Rutgers Cancer Institute's Gastrointestinal Oncology Program when he arrives this fall.

Janice M. Mehnert, MD

Favorable Safety Profile Seen in Immunotherapy Drug in Aggressive Form of Lung Cancer

The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer. That is according to data from a phase Ib clinical trial conducted by Janice M. Mehnert, MD, director of Phase I/Investigational Therapeutics at Rutgers Cancer Institute of New Jersey and associate professor of medicine at Rutgers Robert Wood Johnson Medical School, and colleagues at centers around the world.

Jennifer Tsui, PhD

Major Grant from the American Cancer Society Awarded to Rutgers Cancer Institute Researcher

Jennifer Tsui, PhD, a researcher at Rutgers Cancer Institute of New Jersey, has been awarded a $729,000 Mentored Research Scholar Grant in Applied and Clinical Research (MRSG-17-099-01-CPHSPS) from the American Cancer Society to further explore health care delivery and care transitions for underserved cancer patients. Dr. Tsui, who is also an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, will focus on factors that impact transitions from primary care to specialty oncology care.